Chu de Bordeaux
Pessac, France
NCT Number: NCT06535763
The aim of this study is to propose a non-anxiety-inducing method of managing behavioral disorders for patients and healthcare professionals. The main objective of this study is to evaluate the implementation, use and effects of HAPNeSS (Hypnosis Adapted to People with Severe Neurocognitive Disorders) training on the management of residents aged over 75 with moderately severe to severe Alzheimer's disease or a related disorder, who may present behavioral disorders, with caregivers working in EHPAD.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Pessac, France
The HAPNeSS method would offer caregivers the opportunity to find solutions to difficulties encountered (behavioral disorders, difficult care, etc.), to move away from pure technicality to reinvest in the relationship with the patient, and to find soothing, respectful and benevolent channels of communication. The aim of this study is to evaluate the effects of HAPNeSS (Hypnosis Adapted to People with Severe Neurocognitive Disorders) training on the care of residents over 75 with moderately severe to severe Alzheimer's disease or related disorders, who may present behavioral problems.
But also to measure, within each establishment, the effects of the HAPNeSS method, on the professional practices of caregivers (actions implemented, execution of missions, relationship with residents...) and to gather their feelings. These objectives therefore aim to collect and evaluate the effects of this method on the relationship between patients and caregivers, as well as on the latter's QWL. To achieve this, the research team organized 4 visits to the EHPADs participating in the study, spread over 6 months. Training takes place over 3 and then 2 days. Before and after the training, a visit at the beginning and end of the study will enable the scales to be administered and the interviews to be conducted. The data collected will be the subject of a mixed statistical analysis. Throughout the study, the research team will monitor the learning and development of each care professional.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
EHPAD staff meeting the following criteria will be included in the study:
The study will examine the individual perceptions of EHPAD professionals of patients meeting the following criteria:
Exclusion criteria
EHPAD professionals will not be included:
The individual perception of EHPAD professionals of patients meeting these criteria will not be questioned in the study:
Care professionals will be questioned using a self-administered Quality of Life at Work scale, as well as a second scale (before and after training, with one test per day for 3 consecutive working days) asking about the number of work situations involving behavioral disorders in the residents under their care, and how they use the HAPNeSS method to deal with these situations.
The effects of the HAPNeSS method on caregivers' professional practices (actions taken, performance of tasks, relations with residents, etc.) and their feelings on the subject, will be collected in two semi-structured interviews (with half the participants selected at random) conducted before and after the training course by the research team's occupational psychologist.
Time frame: Month 2 and month 6
Number of work situations which the carer feels he/she has had difficulty managing, involving a resident with a neurocognitive disorder and behavioural problems.
Time frame: Month 2 and month 6
Scale QENA, minimum value 69 and maximum value 276. Analysis of feelings and impressions of professionals will be obtained from the analysis of the semi-directed interviews (qualitative analysis).
Contact information is provided by the study sponsor or research team.
Emma SALANNE
CONTACT
Marie FLOCCIA, MD
CONTACT
University Hospital, Bordeaux
Other
Acronym: HAPNeSS-E
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05508789
Alzheimer Disease, Brain Diseases
ABB, Argentina
View Trial DetailsNCT05318976
Alzheimer Disease, Brain Diseases
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT06297590
Alzheimer Disease, Brain Diseases
Maitland, Florida, United States
View Trial DetailsNCT03846492
Aberrant Motor Behavior in Dementia, Alzheimer Disease
Toronto, Ontario, Canada
View Trial Details